Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2005

01-05-2005 | Oral presentation

Radiotherapy in early stage invasive breast cancer: current tendencies

Authors: JA Diaz-Gonzalez, KH Shin, R Martinez-Monge, M Zelefsky

Published in: Breast Cancer Research | Special Issue 1/2005

Login to get access

Excerpt

Breast-conserving treatment (BCT) constitutes the predominant approach to local treatment in early stage invasive breast cancer. This modality of treatment includes breast-conserving surgery (BCS), radiotherapy, and systemic treatment. These three pillars of BCT have been intensively studied during the past few decades to determine their role and possible variations in their application. …
Literature
1.
Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004, 96: 115-121.CrossRefPubMed
2.
Fisher B, Jeong JH, Bryant J, et al: Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet. 2004, 364: 858-868. 10.1016/S0140-6736(04)16981-X.CrossRefPubMed
3.
Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004, 351: 971-977. 10.1056/NEJMoa040587.CrossRefPubMed
4.
Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005, 23: 1726-1735. 10.1200/JCO.2005.09.045.CrossRefPubMed
Metadata
Title
Radiotherapy in early stage invasive breast cancer: current tendencies
Authors
JA Diaz-Gonzalez
KH Shin
R Martinez-Monge
M Zelefsky
Publication date
01-05-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1218

Other articles of this Special Issue 1/2005

Breast Cancer Research 1/2005 Go to the issue

Poster presentation

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

Oral presentation

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit

Oral presentation

Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients

Oral presentation

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer

Oral presentation

Neoadjuvant treatment: the MD Anderson experience

Oral presentation

Preoperative hormonal therapy: results and implications
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits